Michael Broxson
Directeur Technique/Scientifique/R&D chez Takeda Pharmaceuticals U.S.A., Inc.
Profil
Michael Broxson is currently a Director at Molecular Templates OpCo, Inc. and a Vice President, Head-Research & Development at Takeda Pharmaceuticals U.S.A., Inc. He was previously the Chief Executive Officer at Q32 Bio, Inc. and a Director at Molecular Templates, Inc. Broxson received an undergraduate degree from Tulane University (Louisiana) and an MBA degree from The University of Chicago Booth School of Business.
Postes actifs de Michael Broxson
Sociétés | Poste | Début |
---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Directeur Technique/Scientifique/R&D | - |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Broxson
Sociétés | Poste | Fin |
---|---|---|
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Directeur Général | 20/09/2022 |
MOLECULAR TEMPLATES, INC. | Directeur/Membre du Conseil | - |
Formation de Michael Broxson
The University of Chicago Booth School of Business | Masters Business Admin |
Tulane University (Louisiana) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |